Thymosin Alpha-1
Tα1, N-Acetyl-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn
Thymosin Alpha-1 is a potent immunomodulatory peptide that enhances T-lymphocyte function, activates natural killer cells, and strengthens both innate and adaptive immune responses. Originally derived from the thymus gland, it plays a crucial role in immune system maturation and has been extensively studied for treating viral infections, cancer, and immunodeficiency disorders.
Complete Dosing Guide
Quick Reference
Administration Method
Subcutaneous injection with site rotation between thighs, abdomen, and upper arms
Step-by-Step Dosing Protocol
Dosing Guidelines
Standard protocol is 1.6 mg subcutaneous injection twice weekly (Monday/Thursday or Tuesday/Friday schedule). Some protocols use 1.6 mg daily for acute conditions. Maintenance therapy typically continues for 3-6 months with periodic assessment. Immunocompromised patients may require longer duration or higher frequency dosing.
Most people take Thymosin Alpha-1 as a shot under the skin twice a week - like every Monday and Thursday. Each shot is 1.6mg. You typically continue this for 3-6 months while your doctor checks how your immune system is improving. Some people with severe immune problems might need it more often.
Mixing & Injection
Subcutaneous injection using insulin syringes in abdomen, thigh, or upper arm areas. Rotate injection sites to prevent lipodystrophy. Reconstitute lyophilized powder with bacteriostatic water immediately before use. Administer at consistent times (morning/evening) to maintain steady immune activation. Store reconstituted solution refrigerated and use within 14 days.
Subcutaneous injection using insulin syringes in abdomen, thigh, or upper arm areas. Rotate injection sites to prevent lipodystrophy. Reconstitute lyophilized powder with bacteriostatic water immediately before use. Administer at consistent times (morning/evening) to maintain steady immune activation. Store reconstituted solution refrigerated and use within 14 days.
Clinical Administration Guidelines
Injection Protocol
- •Subcutaneous injection per protocol
- •Rotate injection sites
- •Consistent daily timing
- •Follow protocol guidelines
Monitoring Schedule
- •Regular progress monitoring
- •Health parameter monitoring
- •Laboratory monitoring
- •Safety monitoring
Dosage Calculator
Medical Disclaimer
Thymosin Alpha-1 is an investigational peptide not approved by the FDA for medical treatment in the United States. This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers before use, especially for immune-related conditions or during medical treatments.